Zusammenfassung
Die Clostridium-difficile-Infektion bleibt insbesondere auf der Intensivstation ein Problem in der Betreuung und Behandlung von Patienten. Schwere Verläufe und wiederholte Rezidive stellen eine Herausforderung in der Therapie der Infektion dar. Besondere Rücksicht muss auf Patienten mit einem hohen Risiko für die Entwicklung einer schweren Infektion genommen werden. Der Einsatz von Antibiotika sollte sowohl im ambulanten als auch im stationären Bereich sinnvoll und kontrolliert erfolgen. Die Stuhltransplantation oder Fremdstuhltherapie scheint eine Methode mit exzellenten Ergebnissen in der Therapie von schweren oder rezidivierenden Infektionen zu sein, dennoch sind in Zukunft weitere randomisierte kontrollierte Studien nötig.
Abstract
Clostridium difficile infections remain a problem especially for patients in the intensive care unit. The fact that C. difficile infections are strongly associated with antibiotic therapy calls for more caution in the use of antibiotics, especially in patients with a high risk of developing C. difficle infections. Severe infections and recurrent episodes are usually difficult to manage and therapeutic options are often limited. The method of stool transplantation, though not new, has received more attention in recent years, with studies showing stool transplantation to be a promising and easy method which has high clinical cure rates even for recurrent C. difficile infections. However, more randomised and controlled trials are needed to further study the efficacy of stool transplantation in patients with C. difficile infection.
Literatur
Gastmeier P, Weitzel-Kage D, Behnke M et al (2009) Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrobial Agents 33(S1):S19–S23
Bettin K, Clabots C, Mathie P et al (1994) Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 15:697
Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330(4):257–262
Baines SD, O’Connor R, Freeman J et al (2008) Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 62(5):1046–1052
Zar FA, Bakkanagari SR, Moorthi KM et al (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by diesase severity. Clin Infect Dis 45(3):302–307
Mullane KM, Miller MA, Weiss K et al (2011) Efficacy of fidaxomicin versus vancomycin as therapy for clostridium difficile in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis 53:440
Louie TJ, Miller MA, Mullane KM et al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422–431
Cornley OA, Miller MA, Louie TJ et al (2012) Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 55(Suppl 2):S154
Miller MA, Louie T, Mullane K et al (2013) Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis 13:148
Gerding DN, Muto CA, Owens RC Jr (2008) Treatment of Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S32–S42
Apisarnthanarak A, Razavi B, Mundy LM (2002) Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis 35(6):690–696
Nathanson DR, Sheahan M, Chao L, Wallack MK (2001) Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case. Dis Colon Rectum 44(12):1871–1872
Shetler K, Nieuwenhuis R, Wren SM et al (2001) Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis. Surg Endosc 15(7):653–659
Hu MY, Katchar K, Kyne L et al (2009) Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile Infection. Gastroenterology 136:1206
McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97(7):1769–1775
Johnson S, Schriever C, Galang M et al (2007) Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44(6):846–848
Nood E van, Vrieze A, Nieuwdorp M et al (2013) Duodenal Infusion of donor feces for recurrent Clostridium difficile Infection. N Engl J Med 368(5):407–415
Chang JY, Antonopoulos DA, Kalra A et al (2008) Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197(3):435–438
Petrof EO, Gloor GB, Vanner SJ et al (2013) Stool substitute transplant therapy for the eradication of Clostridium difficile infection: RePOOPulating‘ the gut. Microbiome 1:3
Einhaltung ethischer Richtlinien
Interessenkonflikt. A. Ebigbo und H. Messmann geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ebigbo, A., Messmann, H. Problemfeld Clostridium-difficile-Infektion. Med Klin Intensivmed Notfmed 108, 624–627 (2013). https://doi.org/10.1007/s00063-013-0258-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-013-0258-7
Schlüsselwörter
- Infektiöse Darmerkrankung
- Fremdstuhltherapie
- Stuhltransplantation
- Enterokolitis, pseudomembranös
- Biodiversität